Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression: real-world data from the German Cutaneous Lymphoma Network - Blazejak, Christoph; Oymanns, Mathias; Stranzenbach, René; Hillen, Uwe; Mitteldorf, Christina; Nicolay, Jan Peter; Wobser, Marion; Schrüfer, Philipp; Gosmann, Janika; Wehkamp, Ulrike; Booken, Nina; Kreuter, Alexander; et al. (Cancers, 2025)
Gesehen am 19.02.2026